Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Fast and accurate prediction of positive and negative urine cultures by flow cytometry

Authors: Bijan Moshaver, Foppie de Boer, Heidi van Egmond-Kreileman, Ellen Kramer, Coen Stegeman, Paul Groeneveld

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Urinary tract infection (UTI) is a widespread infectious disease in humans. Urine culture, a huge workload in the microbiology laboratory, is still the standard diagnostic test for UTI, but most of the cultures are negative. A reliable screening method could reduce unnecessary cultures and quicken reporting of negative results.

Methods

We evaluated the usefulness of a flow cytometry (FC) screening method in the prediction of positive urine culture to reduce the number of urine cultures. The urine specimens sent to the laboratory for culture were tested with the flow cytometer Accuri C6. FC bacterial counts were compared to standard urine culture results to assess the best cut-off values.

Results

Two hundred nine urine samples were included, of which 79 (37.8 %) were culture positive. On comparing the culture and the FC data in the ROC curve, the FC bacterial counts of ≥106 bacteria/mL provided a reliable screening for bacteriuria with a sensitivity and specificity of 99 and 58 %, respectively. All negative FC results (<106 bacteria/mL) showed a negative predictive value of 99 % with a negative likelihood ratio of 0.02. The FC bacterial counts of ≥108/mL showed a positive predictive value of 99 % with a positive likelihood ratio of 60.9.

Conclusions

Counting bacteria in human urine samples by the FC is a fast, accurate and cost-effective screening method for bacteriuria. Our results showed that FC is able to rule out UTI, which can lead to a substantial reduction (36 %) of urine cultures. It also demonstrated that this method predicts positive cultures accurately.
Literature
1.
go back to reference Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin N Am. 2014;28:1–13.CrossRef Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin N Am. 2014;28:1–13.CrossRef
2.
go back to reference Medina-Bombardó D, Jover-Palmer A. Does clinical examination aid in the diagnosis of urinary tract infections in women? A systematic review and meta-analysis. BMC Fam Pract. 2011;12:111.CrossRefPubMedPubMedCentral Medina-Bombardó D, Jover-Palmer A. Does clinical examination aid in the diagnosis of urinary tract infections in women? A systematic review and meta-analysis. BMC Fam Pract. 2011;12:111.CrossRefPubMedPubMedCentral
3.
go back to reference Devillé WL, Yzermans JC, van Duijn NP, Bezemer PD, van der Windt DA, Bouter LM. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol. 2004;4:4.CrossRefPubMedPubMedCentral Devillé WL, Yzermans JC, van Duijn NP, Bezemer PD, van der Windt DA, Bouter LM. The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol. 2004;4:4.CrossRefPubMedPubMedCentral
4.
go back to reference Gieteling E, van de Leur JJ, Stegeman CA, Groeneveld PH. Accurate and fast diagnostic algorithm for febrile urinary tract infections in humans. Neth J Med. 2014;72(7):356–62.PubMed Gieteling E, van de Leur JJ, Stegeman CA, Groeneveld PH. Accurate and fast diagnostic algorithm for febrile urinary tract infections in humans. Neth J Med. 2014;72(7):356–62.PubMed
5.
go back to reference Little P, Turner S, Rumsby K, Warner G, Moore M, Lowes A, Smith H, Hawke C, Mullee M. Developing clinical rules to predict urinary tract infection in primary care settings: sensitivity and specificity of near patient tests (dipsticks) and clinical scores. Br J Gen Pract. 2006;56(529):606–12.PubMedPubMedCentral Little P, Turner S, Rumsby K, Warner G, Moore M, Lowes A, Smith H, Hawke C, Mullee M. Developing clinical rules to predict urinary tract infection in primary care settings: sensitivity and specificity of near patient tests (dipsticks) and clinical scores. Br J Gen Pract. 2006;56(529):606–12.PubMedPubMedCentral
6.
go back to reference Lammers RL, Gibson S, Kovacs D, Sears W, Strachan G. Comparison of test characteristics of urine dipstick and urinalysis at various test cutoff points. Ann Emerg Med. 2001;38(5):505–12.CrossRefPubMed Lammers RL, Gibson S, Kovacs D, Sears W, Strachan G. Comparison of test characteristics of urine dipstick and urinalysis at various test cutoff points. Ann Emerg Med. 2001;38(5):505–12.CrossRefPubMed
7.
go back to reference Winkens RA, Leffers P, Trienekens TA, Stobberingh EE. The validity of urine examination for urinary tract infections in daily practice. Fam Pract. 1995;12(3):290–3.CrossRefPubMed Winkens RA, Leffers P, Trienekens TA, Stobberingh EE. The validity of urine examination for urinary tract infections in daily practice. Fam Pract. 1995;12(3):290–3.CrossRefPubMed
8.
go back to reference Wiwanitkit V, Udomsantisuk N, Boonchalermvichian C. Diagnostic value and cost utility analysis for urine Gram stain and urine microscopic examination as screening tests for urinary tract infection. Urol Res. 2005;33(3):220–2.CrossRefPubMed Wiwanitkit V, Udomsantisuk N, Boonchalermvichian C. Diagnostic value and cost utility analysis for urine Gram stain and urine microscopic examination as screening tests for urinary tract infection. Urol Res. 2005;33(3):220–2.CrossRefPubMed
9.
go back to reference Shang YJ, Wang QQ, Zhang JR, Xu YL, Zhang WW, Chen Y, Gu ML, Hu ZD, Deng AM. Systematic review and meta-analysis of flow cytometry in urinary tract infection screening. Clin Chim Acta. 2013;424:90–5.CrossRefPubMed Shang YJ, Wang QQ, Zhang JR, Xu YL, Zhang WW, Chen Y, Gu ML, Hu ZD, Deng AM. Systematic review and meta-analysis of flow cytometry in urinary tract infection screening. Clin Chim Acta. 2013;424:90–5.CrossRefPubMed
10.
go back to reference Broeren MA, Bahçeci S, Vader HL, Arents NL. Screening for urinary tract infection with the Sysmex UF-1000i urine flow cytometer. J Clin Microbiol. 2011;49(3):1025–9.CrossRefPubMedPubMedCentral Broeren MA, Bahçeci S, Vader HL, Arents NL. Screening for urinary tract infection with the Sysmex UF-1000i urine flow cytometer. J Clin Microbiol. 2011;49(3):1025–9.CrossRefPubMedPubMedCentral
11.
go back to reference Rüger M, Bensch G, Tüngler R, Reicht U. A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture. Cytometry A. 2012;81(12):1055–66.CrossRefPubMed Rüger M, Bensch G, Tüngler R, Reicht U. A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture. Cytometry A. 2012;81(12):1055–66.CrossRefPubMed
13.
go back to reference Faria-Ramos I, Espinar MJ, Rocha R, Santos-Antunes J, Rodrigues AG, Cantón R, Pina-Vaz C. A novel flow cytometric assay for rapid detection of extended-spectrum beta-lactamases. Clin Microbiol Infect. 2013;19(1):E8–15.CrossRefPubMed Faria-Ramos I, Espinar MJ, Rocha R, Santos-Antunes J, Rodrigues AG, Cantón R, Pina-Vaz C. A novel flow cytometric assay for rapid detection of extended-spectrum beta-lactamases. Clin Microbiol Infect. 2013;19(1):E8–15.CrossRefPubMed
14.
go back to reference Shapiro HM. Practical flow cytometry. 3rd ed. New York: Wiley-Liss; 1994. p. 542. Shapiro HM. Practical flow cytometry. 3rd ed. New York: Wiley-Liss; 1994. p. 542.
15.
go back to reference European Confederation of Laboratory Medicine. European analysis guidelines. Scand J Clin Lab Invest Suppl. 2000;231:1–86. European Confederation of Laboratory Medicine. European analysis guidelines. Scand J Clin Lab Invest Suppl. 2000;231:1–86.
17.
go back to reference Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Morgan GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE, Infectious Disease Society of America, European Society for Microbiology and Infectious Disease. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Disease Society of America and the European Society for Microbiology and Infectious Disease. Clin Infect Dis. 2011;52:e103–20.CrossRefPubMed Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Morgan GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE, Infectious Disease Society of America, European Society for Microbiology and Infectious Disease. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Disease Society of America and the European Society for Microbiology and Infectious Disease. Clin Infect Dis. 2011;52:e103–20.CrossRefPubMed
18.
go back to reference Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Inc.; 2005. p. 885. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Inc.; 2005. p. 885.
19.
go back to reference Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med. 2013;369(20):1883–91.CrossRefPubMedPubMedCentral Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med. 2013;369(20):1883–91.CrossRefPubMedPubMedCentral
Metadata
Title
Fast and accurate prediction of positive and negative urine cultures by flow cytometry
Authors
Bijan Moshaver
Foppie de Boer
Heidi van Egmond-Kreileman
Ellen Kramer
Coen Stegeman
Paul Groeneveld
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1557-4

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.